Robert E. Carraway

Robert E. Carraway's AcademicInfluence.com Rankings

Robert E. Carraway

Medical

#2952

World Rank

#3399

Historical Rank

Pharmacology

#337

World Rank

#388

Historical Rank

medical Degrees

Download Badge

Medical

Robert E. Carraway's Degrees

PhD Pharmacology University of California, Irvine
Bachelors Pharmacy University of California, San Francisco

Why Is Robert E. Carraway Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Robert E. Carraway's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami. (1973) (1391)
Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons (1995) (782)
Characterization of radioimmunoassayable neurotensin in the rat. Its differential distribution in the central nervous system, small intestine, and stomach. (1976) (493)
The amino acid sequence of a hypothalamic peptide, neurotensin. (1975) (382)
Neurotensin: specific binding to synaptic membranes from rat brain. (1977) (239)
Isolation of a tridecapeptide from bovine intestinal tissue and its partial characterization as neurotensin. (1976) (217)
Radioimmunoassay for neurotensin, a hypothalamic peptide. (1976) (201)
Neurotensin neurons in the rat hypothalamus: an immunocytochemical study. (1980) (198)
Autoimmune mechanisms as the basis for human peripartum cardiomyopathy (2002) (188)
CAG expansion affects the expression of mutant huntingtin in the Huntington's disease brain (1995) (177)
Neurotensin stimulates exocytotic histamine secretion from rat mast cells and elevates plasma histamine levels. (1982) (167)
Isolation of human intestinal neurotensin. (1980) (143)
Neurotensin is a proinflammatory neuropeptide in colonic inflammation. (1999) (131)
The synthesis of neurotensin. (1975) (108)
Distribution and immunochemical character of neurotensin-like material in representative vertebrates and invertebrates: Apparent conservation of the COOH-terminal region during evolution (1982) (101)
Involvement of neurotensin in cancer growth: Evidence, mechanisms and development of diagnostic tools (2006) (101)
Hyperglycemic effect of neurotensin, a hypothalamic peptide. (1976) (97)
Neurotensin receptor expression in prostate cancer cell line and growth effect of NT at physiological concentrations (1997) (97)
The stability and metabolism of intravenously administered neurotensin in the rat (1982) (91)
Naloxone blocks transferred preconditioning in isolated rabbit hearts. (2001) (87)
A neurotensin antagonist, SR 48692, inhibits colonic responses to immobilization stress in rats. (1996) (84)
Isolation, structure and biologic activity of chicken intestinal neurotensin (1980) (81)
Isolation, biological and chemical characterization, and synthesis of a neurotensin-related hexapeptide from chicken intestine. (1983) (81)
The amino acid sequence of radioimmunoassayable neurotensin from bovine intestine. (1978) (80)
Involvement of MAP-kinase, PI3-kinase and EGF-receptor in the stimulatory effect of Neurotensin on DNA synthesis in PC3 cells (2004) (77)
Elevation of plasma neurotensinlike immunoreactivity after a meal. Characterization of the elevated components. (1982) (76)
Signaling pathways underlying eosinophil cell motility revealed by using caged peptides. (1998) (75)
Evidence that neurotensin mediates the central effect of leptin on food intake in rat (2001) (74)
Localization of neurotensin immunoreactive nerve fibers in the guinea-pig heart: Evidence derived by immunohistochemistry, radioimmunoassay and chromatography (1982) (67)
Immunohistochemical localization of neurotensin in endocrine cells of the gut (1977) (66)
Myocardial preconditioning factors evoke mesenteric ischemic tolerance via opioid receptors and K(ATP) channels. (2002) (65)
Neurotensin in plasma: immunochemical and chromatographic character of acid/acetone-soluble material. (1980) (64)
Stimulation of luteinizing hormone release after stereotaxic microinjection of neurotensin into the medial preoptic area of rats. (1984) (59)
Structure of a biologically active neurotensin-related peptide obtained from pepsin-treated albumin(s). (1987) (58)
Impact of pregnancy-related heart failure on humoral immunity: clinical relevance of G3-subclass immunoglobulins in peripartum cardiomyopathy. (2005) (57)
Posttranslational Processing of the Neurotensin/Neuromedin‐N Precursor (1992) (57)
Zinc pyrithione induces ERK- and PKC-dependent necrosis distinct from TPEN-induced apoptosis in prostate cancer cells. (2012) (56)
Immunochemical characterization of neurotensin-like peptides in chicken (1980) (56)
Release and degradation of neurotensin during perfusion of rat small intestine with lipid (1985) (53)
Endogenous neurotensin facilitates visceral nociception and is required for stress-induced antinociception in mice and rats (2004) (52)
Differential processing of neurotensin/neuromedin N precursor(s) in canine brain and intestine. (1990) (50)
Neurotensin Activates GABAergic Interneurons in the Prefrontal Cortex (2005) (50)
Involvement of arachidonic acid metabolism and EGF receptor in neurotensin-induced prostate cancer PC3 cell growth (2006) (49)
Organization of a vertebrate cardiac ganglion: a correlated biochemical and histochemical study (1987) (48)
Neurotensin-deficient mice show altered responses to antipsychotic drugs (2001) (46)
Evidence that neurotensin participates in the central regulation of the preovulatory surge of luteinizing hormone in the rat. (1989) (46)
Neurotensin stimulation of mast cell secretion is receptor-mediated, pertussis-toxin sensitive and requires activation of phospholipase C. (1999) (43)
Amphibian neurotensin (NT) is not xenopsin (XP): dual presence of NT-like and XP-like peptides in various amphibia. (1982) (41)
The use of radioimmunoassay to compare the tissue and subcellular distributions of neurotensin and neuromedin N in the cat. (1987) (41)
Role of substance P in several models of bladder inflammation (2004) (40)
Electron paramagnetic resonance studies of ion pairs. Kinetics of the interconversion between different ion pairs and the rapid electron-transfer reaction between anion and neutral molecule (1968) (40)
Synthesis and activities of neurotensin, and its acid and amide analogs: possible natural occurrence of [Gln4]-neurotensin. (1976) (39)
Rapid degradation of neurotensin by stimulated rat mast cells (1991) (38)
Parallel secretion of endogenous 5‐hydroxytryptamine and histamine from mast cells stimulated by vasoactive peptides and compound 48/80 (1984) (37)
Radioimmunoassay for Lys8, Asn9, neurotensin 8–13: Tissue and subcellular distribution of immunoreactivity in chickens (1983) (34)
Evidence for a neurotensin receptor in rat serosal mast cells (1998) (33)
Bacterial peptides with C-terminal similarities to bovine neurotensin (1981) (33)
Enhancement of jejunal absorption of conjugated bile acid by neurotensin in rats. (2001) (32)
Phylogenetic conservatism in the presence of a neurotensin-related hexapeptide in neurons of globus pallidus (1985) (32)
Ganglion cells in the turtle retina contain the neuropeptide LANT-6 (1988) (32)
Pepsin treatment of mammalian plasma generates immunoreactive and biologically active neurotensin-related peptides in micromolar concentrations. (1986) (31)
Alcohol and fatty acid stimulation of neurotensin release from rat small intestine. (1985) (30)
Reproduction of Postprandial Neurotensin Plasma Levels by Intravenous Neurotensin and the Effect of Neurotensin on Exocrine Pancreatic Secretion in Humans (1986) (30)
Phylogeny of the Gastroenteropancreatic Neuroendocrine System: A Review (1981) (30)
Neurotensin elevates hematocrit and plasma levels of the leukotrienes, LTB4, LTC4, LTD4 and LTE4, in anesthetized rats (1991) (30)
Quantitation of substance-P and its metabolites in plasma and synovial fluid from patients with arthritis. (1993) (30)
Endogenous neurotensin facilitates enterohepatic bile acid circulation by enhancing intestinal uptake in rats. (2001) (29)
Stimulated rat mast cells generate histamine-releasing peptide from albumin (1993) (29)
BON cells display the intestinal pattern of neurotensin/neuromedin N precursor processing (1994) (29)
Structures of histamine-releasing peptides formed by the action of acid proteases on mammalian albumin(s). (1989) (29)
Evidence for the presence of xenopsin-related peptide(s) in the gastric mucosa of mammals. (1985) (27)
Singlet-Singlet and Triplet-Triplet Energy Transfer in Bichromophoric Peptides (1999) (26)
Occurrence of neurotensin-immunoreactive cells in the digestive tract of lower vertebrates and deuterostomian invertebrates (1980) (26)
Ultrastructure of the gut neurotensin cell (1977) (25)
Generation of xenopsin-related peptides during acid extraction of gastric tissues. (1985) (24)
Delta opiates increase ischemic tolerance in isolated rabbit jejunum. (2002) (23)
Neurotensin decreases pepsin output and gastrointestinal motility in chickens. (1997) (23)
Immunocytochemical localization of LANT-6-like immunoreactivity within neurons in the inner nuclear and ganglion cell layers in vertebrate retinas (1987) (23)
Immunoreactive neurotensin levels in pancreas: elevation in diabetic rats and mice. (1981) (22)
Presence of neurotensin and neuromedin-N within a common precursor from a human pancreatic neuroendocrine tumor. (1988) (22)
A CRITICAL ANALYSIS OF THREE APPROACHES TO RADIOIMMUNOASSAY OF PEPTIDES: APPLICATIONS TO THE STUDY OF THE NEUROTENSIN FAMILY * (1982) (22)
Neurotensin enhances agonist-induced cAMP accumulation in PC3 cells via Ca2+-dependent adenylyl cyclase(s) (1998) (21)
8 – Neurotensin and Related Substances (1978) (21)
Precursor forms of neurotensin (NT) in cat: processing with pepsin yields NT-(3–13) and NT-(4–13) (1987) (21)
Plasma protein(s) yields met-enkephalin-related peptides in near-micromolar concentrations when treated with pepsin. (1986) (21)
Distribution patterns of neurotensin-like immunoreactive cells in the gastro-intestinal tract of higher vertebrates (2004) (20)
Characterization of large neuromedin-N using antisera towards regions of the neurotensin/neuromedin-N precursor (1991) (20)
The amino acid sequence of bovine hypothalamic substance P. Identity to substance P from colliculi and small intestine. (1979) (20)
Synergistic effects of neurotensin and beta-adrenergic agonist on 3,5-cyclic adenosine monophosphate accumulation and DNA synthesis in prostate cancer PC3 cells. (1999) (20)
Purification of large neuromedin N (NMN) from canine intestine and its identification as NMN-125. (1991) (19)
Neurotensin-like immunoreactivity in the nervous system of hydra (2004) (19)
Tissue-specific processing of neurotensin/neuromedin-N precursor in cat (1993) (18)
Use of antiserum to neurotensin reveals a physiological role for the peptide in rat prolactin release. (1988) (18)
Polyphenolic Antioxidants Mimic the Effects of 1,4-Dihydropyridines on Neurotensin Receptor Function in PC3 Cells (2004) (18)
Plasma levels of human neurotensin: Methodological and physiological considerations (1991) (17)
Binding and biologic activity of neurotensin in guinea pig ileum (1994) (17)
Effects of GTP analogs and metal ions on the binding of neurotensin to porcine brain membranes (1993) (17)
Xenopsin-related peptide generated in avian gastric extracts (1988) (17)
Ca2+ Channel Blockers Enhance Neurotensin (NT) Binding and Inhibit NT-Induced Inositol Phosphate Formation in Prostate Cancer PC3 Cells (2003) (16)
HMC-1 human mast cells synthesize neurotensin (NT) precursor, secrete bioactive NT-like peptide(s) and express NT receptor NTS1 (2011) (16)
Canine neurotensin, neurotensin6–13 and neuromedin N: primary structures and receptor activity (1990) (16)
Isolation and structures of xenopsin-related peptides from rat stomach, liver and brain (1990) (16)
Involvement of mast cells in basal and neurotensin-induced intestinal absorption of taurocholate in rats. (2004) (15)
Changes in neurotensin-like immunoreactivity during menopausal hot flashes. (1985) (15)
Characterization of immunoreactive substance P and neurotensin in the goldfish retina. (1987) (14)
Neurotensin elevates hepatic bile acid secretion in chickens by a mechanism requiring an intact enterohepatic circulation. (2000) (14)
A multihormonal tumor of the pancreas producing neurotensin (1981) (14)
Insulin-like growth factor (IGF) induced proliferation of human lung fibroblasts is enhanced by neurotensin (2005) (13)
A common precursor to neurotensin and LANT6 and its differential processing in chicken tissues (1993) (13)
Neurotensin receptor binding and neurotensin-induced growth signaling in prostate cancer PC3 cells are sensitive to metabolic stress (2007) (12)
Potential precursors to neuromedin N in the cat and their processing by pepsin. (1987) (12)
Regulation of neurotensin receptor function by the arachidonic acid-lipoxygenase pathway in prostate cancer PC3 cells. (2006) (11)
Isolation, structures, and biologic activity of neurotensin-related peptides generated in extracts of avian tissue. (1987) (11)
Neurotensin modulates the composition of pancreatic exocrine secretions in chickens. (1999) (11)
Xenopsin-related peptide(s) are formed from xenopsin precursor by leukocyte protease(s) and cathepsin D (1991) (11)
Enhanced expression of neurotensin/neuromedin N mRNA and products of NT/NMN precursor processing in neonatal rats (1993) (11)
Effect of disodium cromoglycate (DSCG) and antihistamines on postirradiation cerebral blood flow and plasma levels of histamine and neurotensin. (1988) (10)
Neurotensin levels in the hepatic-portal circulation are inversely related to the circadian feeding cycle in rats. (1987) (9)
Isolation and sequence of canine xenopsin and an extended fragment from its precursor (1990) (9)
Inhibition of Neurotensin-Stimulated Mast Cell Secretion and Carboxypeptidase A Activity by the Peptide Inhibitor of Carboxypeptidase A and Neurotensin-Receptor Antagonist SR 48692 (1998) (9)
Distribution of galanin-like peptide in various tissues of Necturus maculosus (2004) (9)
Enhanced vascular permeability is hypothesized to promote inflammation-induced carcinogenesis and tumor development via extravasation of large molecular proteins into the tissue. (2012) (9)
Importance of thiol group(s) in the binding of 125I-labeled neurotensin to membranes from porcine brain (1993) (9)
Induction of the neurotensin (NT) gene in PC12 cells gives rise to NT precursor (∼88%), NT(3–13)-like peptide (∼10%), and NT (∼2%) (1993) (9)
Chicken liver contains a large quantity of a G-protein-linked neurotensin receptor (1995) (9)
Isolation and quantitation of several new peptides from the canine neurotensin/neuromedin N precursor (1992) (9)
Generation of immunoreactive neurotensin(s) and enkephalin(s) by pepsin-treatment of plasma. (1986) (9)
Protein kinase C inhibitors alter neurotensin receptor binding and function in prostate cancer PC3 cells (2008) (8)
Pepsin-mediated processing of synthetic precursor-like sequence yields neurotensin-like peptide (1992) (8)
Inhibitory effects of the neurotensin8–13 analogs Asp13-NT8–13 and Asp12-NT8–13 on mast cell secretion (2005) (8)
Stimulation of renin secretion by ethacrynic acid is independent of Na(+)-K(+)-2Cl- cotransport. (1990) (8)
Neurotensin and related peptides (1989) (7)
Neurotensin-related peptides inhibit spontaneous longitudinal contractions of porcine distal jejunum (1990) (7)
Mast cell histamine-releasing activity from stimulated rat neutrophils. (1988) (6)
The effect of neurotensin on insulin-induced proliferation of human fibroblasts (2004) (6)
RELATIONSHIPS BETWEEN NEUROTENSIN AND PANCREATIC SECRETION IN THE DOG (1982) (6)
High Affinity Binding of 125I-Neurotensin to Dispersed Cells from Chicken Liver and Brain (1997) (6)
Xenopsin stimulates exocrine pancreatic secretion in the dog (1982) (6)
Generation of histamine‐releasing activity from serum albumin by medium derived from stimulated neutrophils of rat (1989) (6)
Histamine releasing peptide (HRP) has proinflammatory effects and is present at sites of inflammation. (2003) (6)
Purification, characterization, and spasmogenic activity of neurotensin from the toad Bufo marinus (1998) (5)
LIPID STIMULATION OF NEUROTENSIN RELEASE FROM RAT SMALL INTESTINE (1982) (5)
Exocrine secretion and processing of pro-xenopsin in rat gastric lumen. (1990) (5)
Co-localization of xenopsin and gastrin immunoreactivity in gastric antral G-cells (1986) (5)
Release of avian neurotensin in response to intraluminal contents in the duodenum of chickens. (2013) (5)
Cellular mechanism of stimulation of renin secretion by the mercurial diuretic mersalyl. (1991) (5)
Amino acid composition of cytochrome P-450scc from bovine corpus luteum. (1982) (5)
Formation of histamine-releasing activity from albumin by medium conditioned by endotoxin-stimulated rat peritoneal macrophages (2005) (4)
Peptides in the primitive nervous system of coelenterates (1983) (4)
Rapid proteolytic generation of neurotensin-related peptide(s) and biologic activity during extraction of rat and chicken gastric tissues. (1984) (4)
Disruption of ERK1/2 Sensitizes Radiation Resistance Prostate Cancer Cells to Paclitaxel and Ionizing Radiation (2014) (4)
Chromatographic and immunochemical characterization of neurotensin in cat adrenal gland and its release during splanchnic nerve stimulation. (1986) (4)
Methyl 5-diazolevulinate intervention in chemically induced porphyria of rats (1969) (3)
Histamine‐Releasing Peptide Is Formed from Albumin by Stimulated Rat Mast Cells a (1992) (3)
Agonist induced conformation alteration of neurotensin receptor and the mechanism behind Na+ inhibition of 125I-NT binding. (1999) (3)
Neurotensin and cholecystokinin contract gallbladder circular muscle in chickens. (2013) (3)
A new endocrine tumor entity — A multihormonal neurotensinoma (1980) (3)
Preparative electrophoresis of histones in solubilizable polyacrylamide gels. (1982) (3)
Generation of xenopsin-related peptides from tissue precursors by media conditioned by endotoxin-stimulated rat peritoneal macrophages (1991) (3)
Post-translational processing of regulatory peptides (1993) (2)
Immunohistochemical and Biochemical (LANT6)-Related Peptides in the Basal Ganglia of Pigeons, Turtles, and Hamsters Studies on Lys8-Asng-Neurotensin 8-13 (1987) (2)
Cardioprotective factor released from rabbit heart during brief preconditioning ischemia is captured by a hydrophobic matrix (2000) (2)
ERK1 Mediated Epithelial-Mesenchymal Transition and Neuroendocrine Development in Prostate Cancer Cells That Survive High-dose Ionizing Radiation (2012) (2)
Induction of the neurotensin (NT) gene in PC12 cells gives rise to NT precursor (approximately 88%), NT(3-13)-like peptide (approximately 10%), and NT (approximately 2%). (1993) (2)
Implication of two receptor types, one releasing acetylcholine (Kd, 0.15nM) and one substance P (Kd, 2.5nM), which mediate the contractile effect of neurotensin in guinea pig ileum (1992) (1)
Abstract C50: Down-regulation of Bcl2 sensitizes radiation resistance prostate cancer cells to ionizing radiation. (2013) (1)
Phylogenesis of neurotensin-like immunoreactive gut cells (1980) (1)
Pro-xenopsin(s) in vesicles of mammalian brain, liver, stomach and intestine is apparently released into blood and cerebral spinal fluid (2000) (1)
Mast cell histamine mediates neurotensin-enhanced 3H-taurocholate absorption in jejunum (2001) (1)
300. Neurotensin and metabolites in CSF of patients with schizophrenia and controls (1996) (1)
Neurotensin is localized to paracrine cells in the urinary bladder of the turtle, Chrysemys picta. (1990) (1)
Expression of delta opioids in heart and other tissues from summer‐active and hibernating woodchucks (2008) (1)
Research note: cardiovascular effects of neurotensin in anesthetized White Leghorn hens. (1993) (0)
circulation by enhancing intestinal uptake in rats Endogenous neurotensin facilitates enterohepatic bile acid (2013) (0)
Radio immunoassay for 8 lysine 9 asparagine neurotensin 8 13 tissue and sub cellular distribution of immuno reactivity in chickens (1983) (0)
A novel role for the neuropeptide neurotensin in chronic colitis (2000) (0)
Interactive report Evidence that neurotensin mediates the central effect of leptin on food (2001) (0)
Aggressive phenotype for prostate cancer cells that survive high-dose ionizing radiation. (2012) (0)
Aggressive phenotype for prostate cancer cells that survive high-dose ionizing radiation. (2012) (0)
Esophageal tissue content of neurotensin (NT) is significantly higher in patients with nonerosive reflux disease (NERD) as compared to those with erosive esophagitis (2001) (0)
The Relationship Between the Esophageal Tissue Content of Neurotensin and the Presence or Absence of Esophageal Inflammation (2004) (0)
4 N eurotensin and related peptides (0)
Prostate Cancer Cell Growth: Stimulatory Role of Neurotensin And Mechanism of Inhibition by Flavonoids as Related to Protein Kinase C (2008) (0)
Award Number: W81XWH-06-1-0242 TITLE: Prostate Cancer Cell Growth: Stimulatory Role of Neurotensin and Mechanism of Inhibition by Flavonoids as Related to Protein Kinase C PRINCIPAL INVESTIGATOR: (2007) (0)
Introduction (2006) (0)
CHAPTER 102 – Neurotensin (2006) (0)
Prostate Cancer Cell Growth: Role of Neurotensin in Mediating Effect of Dietary Fat and Mechanism of Action (2004) (0)
Differential Roles Between ERK1 and ERK2 on Sensitivity of Radiation Resistance Prostate Cancer Cells in Response to Ionizing Radiation (2015) (0)
Novel Magnetic Resonance Imaging strategy targeting Neurotensin Receptors in detection of Prostate Cancer (2017) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Robert E. Carraway?

Robert E. Carraway is affiliated with the following schools:

Worcester Polytechnic Institute
University of Massachusetts Medical School
University of Massachusetts